GWAS-loci mapping analyses revealed a GWAS-identified bladder cancer risk SNP near those used to predict expression of FAM53A (rs798766 located in TACC3 near FGFR3)4–6. The gene discussed is FGFR3; the disease is urinary bladder cancer.